Literature DB >> 1928134

Development of medication-use indicators by the Joint Commission on Accreditation of Healthcare Organizations.

D M Nadzam1.   

Abstract

The development of indicators for monitoring medication use is described. The Joint Commission on Accreditation of Healthcare Organizations is establishing a national database for use in measuring performance. Initially, indicators were developed for specialties or clinical departments and for disease entities or procedures; now, indicators for key functions that cross departmental and specialty lines, such as medication use, are under development. An interdisciplinary core group constructed a medication-use flow chart depicting prescribing, dispensing, administering, and monitoring patient response; systems management/control was recognized as a fifth component. Sixteen processes were identified for which indicators were developed. Proposed indicators are now being tested in a small number of hospitals. The indicator data will enable institutions to identify areas for improvement. Although the Joint Commission will not use indicator rates per se to determine accreditation, it will ask an institution to provide an interpretation of indicator data that differ markedly from previous data or data for comparable institutions and to review its strategy for analyzing the rates. Use of indicator data will enhance the accreditation process by allowing for ongoing monitoring of particular aspects of performance between onsite surveys.

Entities:  

Mesh:

Year:  1991        PMID: 1928134

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  7 in total

1.  A conceptual framework for evaluating outpatient electronic prescribing systems based on their functional capabilities.

Authors:  Douglas S Bell; Shan Cretin; Richard S Marken; Adam B Landman
Journal:  J Am Med Inform Assoc       Date:  2003-10-05       Impact factor: 4.497

Review 2.  [The (non)sense of certification in intensive care medicine. The problem of the detection of suitable indicator systems].

Authors:  D A Vagts; M Bauer; J Martin
Journal:  Anaesthesist       Date:  2009-01       Impact factor: 1.041

3.  Hospital pharmacy practice in Saudi Arabia: Prescribing and transcribing in the Riyadh region.

Authors:  Mohammed S Alsultan; Fowad Khurshid; Heba J Salamah; Ahmed Y Mayet; Ahmed H Al-Jedai
Journal:  Saudi Pharm J       Date:  2011-11-10       Impact factor: 4.330

4.  Maximizing Benefits With the Medication Use Evaluation Process.

Authors:  Sondra Davis; Patra D Rungruangphol; Caitlin M Gibson
Journal:  Hosp Pharm       Date:  2018-05-08

Review 5.  Pharmaceutical care versus traditional drug treatment. Is there a difference?

Authors:  C D Hepler; T J Grainger-Rousseau
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

6.  Validity of performance indicators for assessing prescribing quality: the case of asthma.

Authors:  Lisa G Pont; Petra Denig; Thys van der Molen; Willem Jan van der Veen; Flora M Haaijer-Ruskamp
Journal:  Eur J Clin Pharmacol       Date:  2003-11-18       Impact factor: 2.953

7.  Quality indicators for responsible use of medicines: a systematic review.

Authors:  Kenji Fujita; Rebekah J Moles; Timothy F Chen
Journal:  BMJ Open       Date:  2018-07-16       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.